Pharmacokinetic basis for dosing high‐dose methotrexate in infants and young children with malignant brain tumours

AIMS: No population pharmacokinetic studies of high‐dose methotrexate (HDMTX) have been conducted in infants with brain tumours, which are a vulnerable population. The aim of this study was to evaluate HDMTX disposition in these children to provide a rational basis for MTX dosing. METHODS: Patients...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Clin Pharmacol
Main Authors: Panetta, John C., Roberts, Jessica K., Huang, Jie, Lin, Tong, Daryani, Vinay M., Harstead, K. Elaine, Patel, Yogesh T., Onar‐Thomas, Arzu, Campagne, Olivia, Ward, Deborah A., Broniscer, Alberto, Robinson, Giles, Gajjar, Amar, Stewart, Clinton F.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7015755/
https://ncbi.nlm.nih.gov/pubmed/31657864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14160
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki